BioLife Solutions, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.35 | -$0.25 | -$0.31 |
| Q2 2024 | 1 | -$0.16 | -$0.11 | -$0.14 |
| Q3 2024 | 1 | -$0.09 | -$0.06 | -$0.08 |
| Q4 2024 | 4 | -$0.19 | -$0.02 | -$0.09 |
| Q1 2025 | 1 | -$0.07 | -$0.05 | -$0.07 |
| Q2 2025 | 1 | -$0.05 | -$0.03 | -$0.04 |
| Q3 2025 | 1 | -$0.03 | -$0.02 | -$0.03 |
| Q4 2025 | 1 | -$0.03 | -$0.02 | -$0.03 |
| Q1 2026 | 1 | $0.01 | $0.01 | $0.01 |
| Q2 2026 | 1 | $0.02 | $0.02 | $0.02 |
| Q3 2026 | 1 | $0.02 | $0.02 | $0.02 |
| Q4 2026 | 1 | $0.03 | $0.05 | $0.04 |
BioLife Solutions, Inc. Earnings Date And Information
BioLife Solutions, Inc. last posted its earnings results on Thursday, August 8th, 2024. The company reported $-0.06 earnings per share for the quarter, topping analysts' consensus estimates of $-0.14 by $0.08. The company had revenue of 30.57 M for the quarter and had revenue of 143.27 M for the year. BioLife Solutions, Inc. has generated $-2 earnings per share over the last year ($-1.52 diluted earnings per share) and currently has a price-to-earnings ratio of -22.51. BioLife Solutions, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
BioLife Solutions, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.04 | $25.54 M | $30.57 M | ||
| 08/09/2024 | Q2 2024 | -$0.45 | $23.95 M | $28.33 M | ||
| 05/10/2024 | Q1 2024 | -$0.22 | $31.73 M | |||
| 02/29/2024 | Q4 2023 | -$0.36 | -$0.30 | 0.06 | $32.73 M | |
| 11/09/2023 | Q3 2023 | -$0.38 | -$0.67 | -0.29 | $33.01 M | $33.33 M |
| 08/09/2023 | Q2 2023 | -$0.23 | $43.64 M | $39.51 M | ||
| 05/11/2023 | Q1 2023 | -$0.32 | $37.70 M | |||
| 03/31/2023 | Q4 2022 | -$1.15 | $44.26 M | |||
| 11/09/2022 | Q3 2022 | -$0.18 | -$0.23 | -0.05 | $42.06 M | $40.75 M |
| 08/09/2022 | Q2 2022 | -$0.20 | -$1.71 | -1.51 | $39.17 M | $40.53 M |
| 05/10/2022 | Q1 2022 | -$0.17 | $36.22 M | |||
| 03/31/2022 | Q4 2021 | -$0.37 | $37.30 M | |||
| 11/15/2021 | Q3 2021 | $0.00 | $31.59 M | $33.80 M | ||
| 08/16/2021 | Q2 2021 | $0.20 | $27.58 M | $31.20 M | ||
| 05/17/2021 | Q1 2021 | -$0.03 | $16.85 M | |||
| 03/31/2021 | Q4 2020 | -$0.06 | $14.73 M | |||
| 11/09/2020 | Q3 2020 | -$0.04 | $10.78 M | $11.28 M | ||
| 08/10/2020 | Q2 2020 | -$0.70 | $9.57 M | $9.92 M | ||
| 05/29/2020 | Q1 2020 | $0.87 | $12.16 M | |||
| 05/15/2020 | Q4 2019 | $0.02 | $8.30 M |
BioLife Solutions, Inc. Earnings: Frequently Asked Questions
-
When is BioLife Solutions, Inc.'s earnings date?
BioLife Solutions, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
-
Did BioLife Solutions, Inc. beat their earnings estimates last quarter?
In the previous quarter, BioLife Solutions, Inc. (:BLFS) reported $-0.06 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.14 by $0.08.
-
How can I listen to BioLife Solutions, Inc.'s earnings conference call?
The conference call for BioLife Solutions, Inc.'s latest earnings report can be listened to online.
-
How can I read BioLife Solutions, Inc.'s conference call transcript?
The conference call transcript for BioLife Solutions, Inc.'s latest earnings report can be read online.
-
How much revenue does BioLife Solutions, Inc. generate each year?
BioLife Solutions, Inc. (:BLFS) has a recorded annual revenue of $143.27 M.
-
How much profit does BioLife Solutions, Inc. generate each year?
BioLife Solutions, Inc. (:BLFS) has a recorded net income of $143.27 M. BioLife Solutions, Inc. has generated $-1.52 earnings per share over the last four quarters.
-
What is BioLife Solutions, Inc.'s price-to-earnings ratio?
BioLife Solutions, Inc. (:BLFS) has a price-to-earnings ratio of -22.51 and price/earnings-to-growth ratio is -0.68.
